Question 1

What is the current price of Inhibikase Therapeutics, Inc. - Common Stock (IKT) stock?

Accepted Answer

Inhibikase Therapeutics, Inc. - Common Stock is currently trading at $1.75 with a -1.13% change.

Question 2

What sector is Inhibikase Therapeutics, Inc. - Common Stock in?

Accepted Answer

Inhibikase Therapeutics, Inc. - Common Stock operates in the Healthcare sector, specifically in the Biotechnology industry.

Question 3

What is Inhibikase Therapeutics, Inc. - Common Stock's market cap?

Accepted Answer

Inhibikase Therapeutics, Inc. - Common Stock has a market capitalization of approximately $231.06 million.

Question 4

Where can I find Inhibikase Therapeutics, Inc. - Common Stock financial statements?

Accepted Answer

QuantSight Pro provides comprehensive financial statements for Inhibikase Therapeutics, Inc. - Common Stock including income statements, balance sheets, and cash flow statements with quarterly and annual data.